Back
BridgeBio Pharma 10K Form
Sell
39
BBIO
BridgeBio Pharma
Last Price:
26.81
Seasonality Move:
21.04%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BBIO News And Ratings
See the #1 stock for the next 7 days that we like better than BBIO
BBIO Financial Statistics
Sales & Book Value
| Annual Sales: | $9.3M |
|---|---|
| Cash Flow: | $72.26M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-5.81 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -2.63000 |
|---|---|
| Net Income (TTM): | $-453.82M |
| Gross Margin: | $6.86M |
| Return on Equity: | 0% |
| Return on Assets: | -67.76% |
BridgeBio Pharma Earnings Forecast
Key BridgeBio Pharma Financial Ratios
- The Gross Profit Margin over the past 7 years for BBIO is 73.71%.
- The Selling, General & Administrative Expenses for BBIO have been equal to 1,618.73% of Gross Profit Margin.
- The Research & Development expenses have been 4,898.54% of Revenue.
- The Interest Expense is -12.64% of Operating Income.
- The Net Earning history of BBIO is -6,913.92% of Total Revenues.
- Per Share Earnings over the last 7 years have been positive in 1 years.
BridgeBio Pharma Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | BBIO |
| CUSIP: | 10806X |
| Website: | bridgebio.com |
Debt
| Debt-to-Equity Ratio: | -1.57 |
|---|---|
| Current Ratio: | 4.59 |
| Quick Ratio: | 3.34 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
BBIO Technical Analysis vs Fundamental Analysis
Sell
39
BridgeBio Pharma (BBIO)
is a Sell
Is BridgeBio Pharma a Buy or a Sell?
-
BridgeBio Pharma stock is rated a Sell
The current BridgeBio Pharma [BBIO] share price is $25.96. The Score for BBIO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.